FDA Clearance Tracker · P110023-S056
EVERFLEX SELF-EXPANDING PERIPHERAL STENT SYSTEM (EVERFLEX)
Last checked: Nov 20, 2026Latest source record: Aug 5, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Aug 5, 2025
Approved
Time to decision
187 days
Received Jan 30, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P110023-S056
- Device name
- EVERFLEX SELF-EXPANDING PERIPHERAL STENT SYSTEM (EVERFLEX)
- Applicant
- Medtronic Vascular, Inc.
- Applicant location
- Plymouth, MN
- Received
- Jan 30, 2025
- Decided
- Aug 5, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P110023
Device type
- Device type
- STENT, SUPERFICIAL FEMORAL ARTERY (NIP)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for a line extension for the SFA/PPA indication, which includes the addition of a 5.0mm stent diameter and reduction in minimum rated vessel diameter to 4.0 mm
Source documents
Other decisions for Medtronic Vascular, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K202800 · Decided Nov 18, 2020 · 56 days after receipt
Device type: Catheter, Angioplasty, Peripheral, Transluminal (LIT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.